Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Esketamine on Postoperative Pain, Anxiety and Depression in Patients Undergoing Tumor Surgery
NCT04613869Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in postoperative pain, anxiety disorder and major depressive disorder (MDD) (3 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Incidence of moderate to severe pain at 72 hours and Pain score at 72 hours. Status: unknown.
02
Drugs
esketamine
03
Conditions
postoperative painanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04613869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04613869.